Yes .Lanstead understands the bio space very well and as the second largest shareholder in Neuren they obviously believe the same as the directors that the company is materially undervalued at the current price.In my opinion when the overseas buying starts they will have to buy on market as Neuren stated today that they have plenty of money so they definetely will not have to have a capital raise .
NEU Price at posting:
$1.09 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)